Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stephen Lockyer Appointed MedX CEO - Medical Product Outsourcing

What are you searching for?

Sign in
People

Stephen Lockyer Appointed MedX CEO

New leader joined the company's Board of Directors in April.

By: Michael Barbella

Managing Editor, Rodman Media

MedX Health Corp. has named Stephen Lockyer as CEO, succeeding Naman Damaghlatrous, who resigned both as an officer and company director.
 
“Stephen, who became a major investor in the company in recent months, and who joined the board in April, 2023, brings extensive knowledge and years of financial management and entrepreneurial experience, and was instrumental in the introduction of the project with PharmaChoice which has been launched in Canada,” MedX Board Chairman Ken McKay said.
 
“I am very enthusiastic for the future of MedX, and I look forward to building on the opportunities that are now opening up,” Lockyer stated.
 
headquartered in Ontario, Canada, Medx is a medical device and software company focused on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also imbedded in its products SIAMETRICS, SIMSYS, and MoleMate, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil, and Turkey. 

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters